Nitroso-oxidative stress after activation of 5-HT₄ receptors under conditions of colitis in rats

1. Takagi T, Naito Y, Yoshikawa T. Free radicals in inflammatory bowel disease. Free Radical Biology in Digestive Diseases. Front Gastrointest Res. Basel, Karger. 2011;29:128-36.Search in Google Scholar

2. Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology. 2004;113(4):427-37.10.1111/j.1365-2567.2004.01984.xSearch in Google Scholar

3. Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829-37.10.1093/eurheartj/ehr304Search in Google Scholar

4. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semiquantification, localization, and association with mucosal antioxidants. J Pathol. 2003;201(1):28-36.10.1002/path.1409Search in Google Scholar

5. Garud S., Peppercorn MA. Ulcerative colitis: current treatment strategy and future prospects. Therap Adv Gastroenterol. 2009;2(2): 99-108.10.1177/1756283X09102329Search in Google Scholar

6. Savenkova ML, Mueller DM, Heinecke JW. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem. 1994; 269(32):20394-400.10.1016/S0021-9258(17)32005-7Search in Google Scholar

7. De Ponti F. Pharmacology of serotonin: what a clinician should know. Gut. 2004;53(10):1520-35.10.1136/gut.2003.035568177422715361507Search in Google Scholar

8. El-Merahbi R, Loffler M, Mayer A, Sumara G. The roles of peripheral serotonin in metabolic homeostasis. FEBS Lett. 2015;589(15):1728-34.10.1016/j.febslet.2015.05.05426070423Search in Google Scholar

9. Schimmack S, Svejda B, Lawrence B, Kidd M, Modlin I. The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors. Langenbeck’s Arch Surg. 2011;396:273-98.10.1007/s00423-011-0739-121274559Search in Google Scholar

10. Manocha M, Khan WI. Serotonin and GI disorders: an update on clinical and experimental studies. Clin Transl Gastroenterol. 2012;3(4):e13.10.1038/ctg.2012.8336567723238212Search in Google Scholar

11. Magro F, Vieira-Coelho MA, Fraga S, Serrao MP, Veloso FT, Ribeiro T et al. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci. 2002;47(1):216-24.10.1023/A:1013256629600Search in Google Scholar

12. Faure C, Patey N, Gauthier C, Brooks EM, Mawe GM. Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterol. 2010;139(1):249-58.10.1053/j.gastro.2010.03.032290261420303355Search in Google Scholar

13. Coleman NS, Foley S, Dunlop SP, Wheatcroft J, Blackshaw E, Perkins AC et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol. 2006;4(7):874-81.10.1016/j.cgh.2006.04.01716797248Search in Google Scholar

14. Ataee R, Ajdary S, Zarrindast M, Rezayat M, Hayatbakhsh MR. Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line. J Cancer Res Clin Oncol. 2010; 136(10):1461-9.10.1007/s00432-010-0801-320306273Search in Google Scholar

15. Coogan PF, Strom BL, Rosenberg L. Antidepressant use and colorectal cancer risk. Pharmacoepidemiol Drug Saf. 2009;18(11): 1111-4.10.1002/pds.1808278329019623565Search in Google Scholar

16. Costedio MM, Coates MD, Danielson AB, Buttolph TR 3^rd, Blaszyk HJ, Mawe GM, et al. Serotonin signaling in diverticular disease. J Gastrointest Surg. 2008;12(8):1439-45.10.1007/s11605-008-0536-5291090518491196Search in Google Scholar

17. Terry N, Margolis GK. Serotonergic mechanisms regulating the GI tract: experimental evidence and therapeutic relevance. Handb Exp Pharmacol. 2017;239:319-42.10.1007/164_2016_103552621628035530Search in Google Scholar

18. Mawe1 GM, Hoffman JM. Serotonin signaling in the gastrointestinal tract: functions, dysfunctions, and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473-86.10.1038/nrgastro.2013.105404892323797870Search in Google Scholar

19. Cloez-Tayarani I, Changeux JP. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol. 2007;81(3):599-606.10.1189/jlb.090654417108054Search in Google Scholar

20. Kushnir-Sukhov NM, Brown JM, Wu Y, Kirshenbaum A, Metcalfe DD. Human mast cells are capable of serotonin synthesis and release. J Allergy Clin Immunol. 2007;119(2):498-9.10.1016/j.jaci.2006.09.00317291861Search in Google Scholar

21. Nakamura K, Sato T, Ohashi A, Tsurui H, Hasegawa H. Role of a serotonin precursor in development of gut microvilli. Am J Pathol. 2008;172(2):333-4.10.2353/ajpath.2008.070358231235518202184Search in Google Scholar

22. O’Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood. 2016;107(3):1010-7.10.1182/blood-2005-07-2903Search in Google Scholar

23. Bassotti G, Antonelli E, Villanacci V, Baldoni M, Dore MP. Colonic motility in ulcerative colitis. United European Gastroenterol J. 2014; 2(6):457-62.10.1177/2050640614548096Search in Google Scholar

24. Spohn SN, Bianco F, Scott RB, Keenan CM, Linton AA, O’Neill CH et al. Protective actions of epithelial 5-hydroxytryptamine 4 receptors in normal and inflamed colon. Gastroenterology. 2016;151(5):933-44.10.1053/j.gastro.2016.07.032Search in Google Scholar

25. Hoffman JM, Tyler K, Maceachern SJ, Balemba OB, Johnson AC, Brooks EM et al. Activation of colonic mucosal 5-HT4 receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology. 2012;142(4):844-54.10.1053/j.gastro.2011.12.041Search in Google Scholar

26. Kim HS. 5-hydroxytryptamine 4 receptor agonists and colonic motility. J Smooth Muscle Res. 2009;45(1):25-9.10.1540/jsmr.45.25Search in Google Scholar

27. Fedorak RN, Empey LR, MacArthur C, Jewell LD. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology. 1990;98(3):615-25.10.1016/0016-5085(90)90280-ESearch in Google Scholar

28. Fomenko IS, Bondarchuk TI, Biletska LP, Panasyuk NB, Sklyarov OY. Study of role of NO-synthase system in gastric mucosa of rats under the influence of non-steroidal anti-inflammatory drugs on the background of adrenaline-induced stress. Bulletin of Problems in Biology and Medicine. 2013;1(3):245-9. (in Ukrainian)Search in Google Scholar

29. Timirbulatov MA, Seleznyov EI. Increase intensity method of free oxidation lipid containing blood components and it`s diagnostic value. Laboratory Work. 1981;4:209-11. (in Russian)Search in Google Scholar

30. Bradley PP, Christensen RD, Rothstein G. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood. 1982;60:618-22.10.1182/blood.V60.3.618.618Search in Google Scholar

31. Goryachkovskyy AM. Clinical Biochemistry. Second edition, corrected and updated. Odessa; 1998:368. (in Russian)Search in Google Scholar

32. Korolyuk MA, Ivanova LI, Mayorova IG. The method of catalase activity determination. Laboratory Work. 1988;1:16-9. (in Russian)Search in Google Scholar

33. Ravaeva MY, Chuyan EN. Changes in activity of nitric oxide synthesis system after the action low mm radiation. Scientific Notes of Tavria National University named after V. I. Vernadsky, Series “Biology, Chemistry”. 2011;24(4):201-10. (in Russian)Search in Google Scholar

34. Davis RH., Mora JJ. Utilization of exogenous and endogenous ornithine by Neurospora crassa. Bacteriology. 1968;96:383-8.Search in Google Scholar

35. Kiselyk IO, Lutsyk MD, Shevchenko LY. Features of the definition of nitrates and nitrites in the peripheral blood of patients with viral hepatitis and jaundice syndrome other etiologies. Laboratory diagnostics. 2001;3:43-5. (in Ukrainian)Search in Google Scholar

36. Mourelle M, Vilaseca J, Guarner F, Salas A, Malagelada JR. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am J Physiol. 1996;270:G425-30.10.1152/ajpgi.1996.270.3.G4258638708Search in Google Scholar

37. Vezza T, Algieri F, Rodriguez-Nogales A, Garrido-Mesa J, Utrilla PM, Talhaoui N et al. Immunomodulatory properties of Olea europaea leaf extract in intestinal inflammation. Mol Nutr Food Res. 2017;61(10):1601066.10.1002/mnfr.20160106628731213Search in Google Scholar

38. Kang JH, Choi S, Jang JE, Ramalingam P, Ko YT, Kim SY et al. Wasabia japonica is a potential functional food to prevent colitis via inhibiting the NF-κB signaling pathway. Food Funct. 2017;8(8):2865-74.10.1039/C7FO00576H28726958Search in Google Scholar

39. Islam J, Koseki T, Watanabe K, Ardiansyah, Budijanto S, Oikawa A et al. Dietary supplementation of fermented rice bran effectively alleviates dextran sodium sulfate-induced colitis in mice. Nutrients. 2017;9(7):E747.10.3390/nu9070747553786128703759Search in Google Scholar

40. Shin SK, Cho JH, Kim EJ, Kim EK, Park DK, Kwon KA et al. Anti-inflammatory and anti-apoptotic effects of rosuvastatin by regulation of oxidative stress in a dextran sulfate sodium-induced colitis model. World J Gastroenterol. 2017;23(25):4559-68.10.3748/wjg.v23.i25.4559550437128740344Search in Google Scholar

41. Zhao L, Xiao HT, Mu HX, Huang T, Lin ZS, Zhong LLD et al. Magnolol, a natural polyphenol, attenuates dextran sulfate sodium-induced colitis in mice. Molecules. 2017;22(7):E1218.10.3390/molecules22071218615229628726741Search in Google Scholar

42. Nieto N. Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci. 2000;45(9):1820-7.10.1023/A:1005565708038Search in Google Scholar

43. Dong WG, Mei Q, Yu JP, Xu JM, Xiang L, Xu Y. Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis. World J Gastroenterol. 2003;9(6):1307-11.10.3748/wjg.v9.i6.1307461180612800246Search in Google Scholar

44. Sklyarov AY, Panasyuk NB, Fomenko IS. Role of nitric oxide synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis. J Physiol Pharmacol. 2011;62(1):65-73.Search in Google Scholar

45. Cross RK, Keith T, Wilson MD. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9(3):179-89.10.1097/00054725-200305000-0000612792224Search in Google Scholar

46. Kochar NI, Chandewal AV, Bakal RL, Kochar PN. Nitric oxide and the gastrointestinal tract. Int J Pharm. 2011;7(1):31-9.10.3923/ijp.2011.31.39Search in Google Scholar

47. Margolis KG, Stevanovic K, Li Z, Yang QM, Oravecz T, Zambrowicz B et al. Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut. 2014;63(6): 928-37.10.1136/gutjnl-2013-304901403468123749550Search in Google Scholar

48. O’Hara JR, Ho W, Linden DR, Mawe GM, Sharkey K A. Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis. Am J Physiol Gastrointest Liver Physiol. 2004;287(5):G998-1007.10.1152/ajpgi.00090.200415231483Search in Google Scholar

49. Mawe GM, Hoffman M. Serotonin signaling in the gastrointestinal tract: functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473-86.10.1038/nrgastro.2013.105404892323797870Search in Google Scholar

50. Sklyarov OY, Kosyy YR, Sklyarov YY. Fundamentals of Gastroenterology. Lviv: Quartus; 2011:28. (In Ukrainian)Search in Google Scholar